Patent · US Active

Extended release, abuse deterrent pharmaceutical compositions

US11096887B2 · kind B2 · utility

0Cited by
110References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2019
Grant dateAug 24, 2021
Priority date
Expiry dateOct 14, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprising at least one active pharmaceutical ingredient or a pharmaceutically acceptable salt thereof, at least one hydrophilic plastomer, at least one hydrophilic elastomer, and at least one deliquescent plasticizer, wherein the pharmaceutical compositions provide extended release of the API and have abuse deterrent properties. Methods for preparing the pharmaceutical compositions in which the components of the composition are humidified such that the deliquescent plasticizer deliquesces, thereby plasticizing the hydrophilic polymers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.